Skip to main content
Clinical Trials/CTRI/2023/10/058331
CTRI/2023/10/058331Not yet recruitingNot Applicable

Incidence and risk factors of Ventilator associated pneumonia in ICU in a tertiary cancer centre: A retrospective study

Malabar cancer centre1 site in 1 country60 target enrollmentStarted: October 10, 2023Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Locations
1
Primary Endpoint
To estimate the incidence of VAP in ICU in a tertiary care centre.

Study Overview

Brief Summary

This study is done to know the incidence and risk factors associated with ventilator associated pneumonia in a cancer institute so that we can better manage such patients.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients who were intubated for more than 48 hours in ICU from 1stJanuary 2020 to 31stDecember 2022.

Exclusion Criteria

  • Patients who were extubated before 48 hours of ICU admission Patients who already had pneumonia or developed pneumonia within 48 hours of intubation.

Outcomes

Primary Outcomes

To estimate the incidence of VAP in ICU in a tertiary care centre.

Time Frame: 6 months,1 year,2 year

Secondary Outcomes

  • To predict the risk factors associated with VAP.(6 months,1 year,2 year)

Investigators

Sponsor Class
Research institution

Study Sites (1)

Loading locations...

Similar Trials

Incidence of Ventilator associated... | Clinical Trial